What amount sold does Spinal Simplicity, LLC report in Form D filings?

The latest linked filings report $21.1M sold across 6 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Spinal Simplicity, LLC's most recent SEC filing?

Spinal Simplicity, LLC's most recent Form D filing was on 2025-07-31.

How many investors does Spinal Simplicity, LLC have?

The most recent Form D filing lists 27 investor(s).

What type of securities does Spinal Simplicity, LLC offer?

Spinal Simplicity, LLC's SEC Form D filings indicate equity offerings.

Spinal Simplicity, LLC

CIK: 0001507286·Biotechnology·Overland Park, KS·Limited Liability Company

Reported Sold

$21,089,968

Total Filings

Identified Offerings

Last Filed

Jul 31, 2025

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Jul 31, 2025Form D/A — Amendment

Reported sold: $6,100,183 · Target: $10,000,000

Rule 506(b)·27 investors

Changed: Reported amount sold, Reported investors

Dec 26, 2024Form D — New notice

Reported sold: $225,000 · Target: $10,000,000

Rule 506(b)·2 investors

Mar 21, 2022Form D/A — Amendment

Reported sold: $10,854,629 · Target: $16,000,000

Rule 506(b)·80 investors

Changed: Reported amount sold, Offering target, Reported investors

May 25, 2021Form D — New notice

Reported sold: $348,500 · Target: $8,000,000

Rule 506(b)·5 investors

Oct 28, 2014Form D — New notice

Reported sold: $250,000 · Target: $4,000,000

Rule 506(b)·3 investors

Mar 14, 2014Form D/A — Amendment

Reported sold: $1,408,969 · Target: $2,550,000

Rule 506(b)·25 investors

Changed: Reported revenue range

Feb 14, 2014Form D — New notice

Reported sold: $1,408,969 · Target: $2,550,000

Rule 506(b)·25 investors

Feb 14, 2013Form D — New notice

Reported sold: $30,000 · Target: $2,550,000

Rule 506·1 investor

Dec 30, 2011Form D/A — Amendment

Reported sold: $2,446,187 · Target: $4,000,000

Rule 506·30 investors

Changed: Reported amount sold, Reported investors, Reported revenue range

Dec 16, 2010Form D — New notice

Reported sold: $703,600 · Target: $4,000,000

Rule 506·11 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

40%

Latest reported sold across 6 identified offerings

$21,089,968

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Todd Moseley

Related Person

Appears on 7 filings

Jonathan Hess

Related Person

Appears on 7 filings

Harold Hess

Related Person

Appears on 5 filings

Tim McCown

Related Person

Appears on 4 filings

Julie Mckee

Related Person

Appears on 3 filings

Harold Hess

Related Person

Appears on 2 filings

Todd Moseley

Related Person

Appears on 2 filings

Jonathan Hess

Related Person

Appears on 2 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Jul 31, 2025	Amendment	$10,000,000	$6,100,183	27
Dec 26, 2024	New	$10,000,000	$225,000	2
Mar 21, 2022	Amendment	$16,000,000	$10,854,629	80
May 25, 2021	New	$8,000,000	$348,500	5
Oct 28, 2014	New	$4,000,000	$250,000	3
Mar 14, 2014	Amendment	$2,550,000	$1,408,969	25
Feb 14, 2014	New	$2,550,000	$1,408,969	25
Feb 14, 2013	New	$2,550,000	$30,000	1
Dec 30, 2011	Amendment	$4,000,000	$2,446,187	30
Dec 16, 2010	New	$4,000,000	$703,600	11

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Amplifi Vascular, Inc.

Biotechnology

Offering target: $12,000,000

Filed Jun 30, 2026